GVDNY Givaudan SA (PK)

ZURICH--SMI advances, edging 0.85% higher to 8204.96. Pharmaceutical giant Roche rises 4.31% after strong sales of its cancer therapies fueled a 17% rise in net income. Crosstown rival Novartis, which reported a day earlier, adds 1.33%, while Actelion, Europe's biggest biotech, climbs 1.3%. Fragrance-and-flavoring maker Givaudan, the day's biggest gainer, climbs 6.34% after reporting a nearly 20% rise in earnings and announcing a big dividend hike. Banks are mixed with Credit Suisse Group dropping 0.68%; UBS gaining 0.06%; and Julius Baer falling 0.11%. Nestle, the world's biggest foodmaker, slides 0.15%.

Write to Zurich bureau at zurichdjnews@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires